Keurig Dr Pepper (DP5) AI Stock Analysis

Keurig Dr Pepper

(XETRA:DP5)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong Cash GenerationImproving operating and free cash flow strengthens KDP’s ability to fund investment, reduce leverage, and maintain capital returns. FCF also represents about 78% of TTM net income, supporting earnings quality and providing financial capacity over the next several quarters.

Negative Factors

Margin CompressionThe decline in net and operating margins shows that recent revenue growth has not translated proportionally into profitability. Unless pricing, productivity, and mix improvements offset cost pressure, weaker margins could limit earnings conversion and reduce funds available for investment.

Keurig Dr Pepper (DP5) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 48.77B
Dividend Yield: 2.51%
Average Volume (3M): 251
Price to Earnings (P/E): 36.1
Beta (1Y): 0.15
Revenue Growth: 18.99%
EPS Growth: -17.78%
Country: Germany
Employees: 30,600
Sector: Consumer Defensive
Sector Strength: 62
Industry: Beverages - Non-Alcoholic

Keurig Dr Pepper Business Overview & Revenue Model

Company Description

Keurig Dr Pepper Inc. is a prominent beverage firm with operations spanning both the United States and global markets. The company structures its business across four primary divisions: Coffee Systems, Packaged Beverages, Beverage Concentrates, and L...

Keurig Dr Pepper Earnings Call Summary

Earnings Call Date:Aug 05, 2026(Q2-2026)|% Change Since:20.90%|Next Earnings Date:Nov 02, 2026

Earnings Call SentimentPositive

The call highlighted substantial enterprise-level strength driven by the JDE Peet's acquisition, robust performance in U.S. Refreshment Beverages (notably energy and CSDs), solid free cash flow and measurable integration progress (single invoice, organizational readiness, deleveraging). These positive outcomes materially outweighed the material but contained headwinds in U.S. Coffee—where elevated green coffee costs, hedging timing and pod category softness pressured sales and profitability. Management reaffirmed full-year guidance and outlined remediation steps (cost synergies, lower-cost inventory flow-through, commercial initiatives), signaling confidence in recovery in H2 while acknowledging near-term commodity volatility and certain timing-related limitations to sustainability of some JDE Peet's Q2 upside.

Positive Updates

Strong Consolidated Top-Line Growth Driven by JDE Peet's

Consolidated net sales grew ~74.6%–75% in Q2 2026, driven by the April 1 acquisition of JDE Peet's; legacy KDP net sales (ex-JDE) grew 7.3% year-over-year (constant currency).

Negative Updates

U.S. Coffee Revenue and Profit Pressure

U.S. Coffee net sales declined 3.2% in Q2, with pod shipments down 11.6% as-reported (down 8.3% excluding Peet's reporting shift). Segment operating income fell 24.7%, driven by higher green coffee input costs, tariff impacts, unfavorable mix shifts and elevated marketing spend.

Company Guidance

KDP reaffirmed full‑year 2026 guidance calling for total company net sales of $25.9–$26.4 billion (including $8.5–$8.7 billion from JDE Peet’s), legacy KDP constant‑currency growth of 4–6% (with the high end most likely), and low‑double‑digit constant‑currency EPS growth (driven roughly by a 6–7 point contribution from JDE Peet’s plus 4–6% from legacy KDP), with an expected ~1 percentage‑point FX tailwind to net sales and EPS; the outlook now assumes an incremental 2% non‑cash depreciation headwind to 2026 EPS offset largely by a one‑time tariff‑refund cash benefit (net neutral to EPS), interest expense of ~$1.12–$1.14 billion, an effective tax rate of ~22–23%, ~1.37 billion diluted weighted average shares outstanding, ~ $190 million pretax coffee JV/convertible preferred P&L costs, a full‑year free cash flow target of ~ $2.5 billion (Q2 FCF was $714 million), and pro forma management leverage of 4.4x at quarter end with an expected year‑end leverage of ~4.1x.

Keurig Dr Pepper Risk Analysis

Keurig Dr Pepper disclosed 49 risk factors in its most recent earnings report. Keurig Dr Pepper reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks

1.The market price of our common stock may decline if we do not achieve the expected benefits and synergies of the JDE Peet's Acquisition.Q2, 2026

2.Our acquisition of JDE Peet's exposes us to significant geopolitical, regulatory, and operational risks in Russia, including the potential loss of those operations, that could adversely affect our business.Q2, 2026

3.Legal proceedings in connection with the JDE Peet's Acquisition could expose us to substantial costs.Q2, 2026

Keurig Dr Pepper Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

DE:DP5 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KO	79Outperform	$404.72B	27.67	42.00%	2.23%	7.74%	12.29%
MNST	79Outperform	$92.74B	43.43	24.96%	―	20.37%	34.79%
PEP	73Outperform	$187.16B	17.23	50.62%	4.23%	6.36%	51.39%
FIZZ	66Neutral	$3.30B	18.98	32.60%	―	-1.80%	-5.87%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
CELH	56Neutral	$7.37B	138.67	4.36%	―	82.86%	-35.81%

* Consumer Defensive Sector Average

Performance Comparison

DE:DP5 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:DP5	Keurig Dr Pepper	32.04	9.80	44.06%
KO	Coca-cola Company	94.08	27.87	42.10%
MNST	Monster Beverage	47.34	14.09	42.35%
FIZZ	National Beverage	35.30	5.22	17.35%
PEP	Pepsico	137.34	-0.67	-0.48%
CELH	Celsius Holdings	29.12	-30.13	-50.85%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Keurig Dr Pepper AI Stock Analysis